SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DRUG: Dragon Pharmaceutical
DRUG 54.480.0%Oct 31 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: caly who wrote (18)1/14/2005 8:28:37 PM
From: Golden Bear  Read Replies (2) of 28
 
When DRUG gets listed on a more senior exchange, the Yahoo Message Boards will open up. In the meantime, I will post here.

Couple of officers just got option awards, priced at 1.18. I don't have a problem at that pricing level. They were effective 1/12/05 and are good until 2010.

There is no cash burn with this company. The old Dragon was only losing 1 cent per share, while Oriental Wave was profitable. After some minor consolidation, the new company should be leaner and more efficient.

They really need to invest in and push the training for cross-sale opportunties with the existing sales force networks- strong incentives should be combined with penalties based on each sales representative's cross-selling performance. Without penalties, sales reps will go for the easy sale: Dragon shareholders don't have time to waste on those reps.

gb
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext